UY26925A1 - Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones - Google Patents
Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composicionesInfo
- Publication number
- UY26925A1 UY26925A1 UY26925A UY26925A UY26925A1 UY 26925 A1 UY26925 A1 UY 26925A1 UY 26925 A UY26925 A UY 26925A UY 26925 A UY26925 A UY 26925A UY 26925 A1 UY26925 A1 UY 26925A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions
- mixtures
- flavoring
- flavoring systems
- flavored
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
Abstract
Sistemas saborizantes para composición farmacéutica líquida y composiciones farmacéuticas conteniéndolas. Los sistemas saborizantes incluyen al menos : un agente edulcorante, dos ingredientes con sabor, y un modificador del sabor que se selecciona del grupo: ácido cítrico, citrato de sodio, cloruro de sodio, y mezclas de los mismos. Al menos dos de los ingredientes saborizados se seleccionan del grupo con sabor : vainilla, menta, mentol, algodón de azúcar, y mezclas de los mismos. El (los) agente (s) edulcorante (s) comprende (n) glicerina, glicirricinato de monoamonio, sacarina sódica, acesulfame potásico, jarabe de maíz de alta fructosa, y/o mezclas de los mismos. Las composiciones incluyen: el sistema saborizante, un sistema solvente, y al menos un agente farmacéuticamente activo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65519200A | 2000-09-05 | 2000-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26925A1 true UY26925A1 (es) | 2002-04-26 |
Family
ID=24627898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26925A UY26925A1 (es) | 2000-09-05 | 2001-09-04 | Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1315487A2 (es) |
JP (1) | JP2004522698A (es) |
AR (1) | AR030715A1 (es) |
AU (1) | AU2001288695A1 (es) |
BR (1) | BR0108433A (es) |
CA (1) | CA2417258A1 (es) |
MX (1) | MXPA03001952A (es) |
PE (1) | PE20020373A1 (es) |
UY (1) | UY26925A1 (es) |
WO (1) | WO2002020057A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5767429B2 (ja) | 1999-11-12 | 2015-08-19 | アッヴィ・インコーポレイテッド | 固体分散剤中の結晶化阻害剤 |
CA2504716A1 (en) * | 2002-11-22 | 2004-06-10 | Roger E. Stier | Oral compositions which mask the salty taste of salts |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
GB2423711B (en) * | 2005-10-24 | 2007-02-14 | Fortune Apex Dev Ltd | Method for preparing a pharmaceutical composition with enhanced mucoadhesion |
WO2013129436A1 (ja) * | 2012-02-29 | 2013-09-06 | 武田薬品工業株式会社 | 経口剤 |
US8771651B2 (en) * | 2012-09-10 | 2014-07-08 | Johnson & Johnson Consumer Companies, Inc. | Mouth rinses and tooth sensitivity treatment compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL111991A (en) * | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
AU3146997A (en) * | 1996-06-03 | 1998-01-05 | Merck & Co., Inc. | Pediatric formulation for hiv protease inhibitors |
-
2001
- 2001-09-04 EP EP01968449A patent/EP1315487A2/en not_active Withdrawn
- 2001-09-04 AU AU2001288695A patent/AU2001288695A1/en not_active Abandoned
- 2001-09-04 AR ARP010104207A patent/AR030715A1/es unknown
- 2001-09-04 MX MXPA03001952A patent/MXPA03001952A/es unknown
- 2001-09-04 PE PE2001000889A patent/PE20020373A1/es not_active Application Discontinuation
- 2001-09-04 BR BRPI0108433-0A patent/BR0108433A/pt not_active IP Right Cessation
- 2001-09-04 CA CA002417258A patent/CA2417258A1/en not_active Abandoned
- 2001-09-04 JP JP2002524540A patent/JP2004522698A/ja not_active Withdrawn
- 2001-09-04 UY UY26925A patent/UY26925A1/es not_active Application Discontinuation
- 2001-09-04 WO PCT/US2001/027415 patent/WO2002020057A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002020057A2 (en) | 2002-03-14 |
BR0108433A (pt) | 2006-06-06 |
MXPA03001952A (es) | 2003-09-10 |
AU2001288695A1 (en) | 2002-03-22 |
CA2417258A1 (en) | 2002-03-14 |
AR030715A1 (es) | 2003-09-03 |
EP1315487A2 (en) | 2003-06-04 |
WO2002020057A3 (en) | 2002-05-10 |
PE20020373A1 (es) | 2002-05-13 |
JP2004522698A (ja) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5979763B2 (ja) | ブロムヘキシンを含む水性組成物 | |
KR970009800A (ko) | 경구 투여용 약제학적 조성물 | |
AR073793A1 (es) | Formulacion farmaceutica liquida que contiene paracetamol. excipiente liquido | |
UY24813A1 (es) | Nuevas preparaciones medicamentosas acuosas para la produccion de aerosoles libres de gas propulsor | |
BRPI0406996A (pt) | Formas de dosagem sólida via transmucosa oral sem açúcar e sua utilização | |
UA79196C2 (en) | Intranasal formulation of rotigotine | |
PE20020307A1 (es) | Forma de dosificacion de farmaco activada por hidrogel | |
RU2007148444A (ru) | Педиатрическая композиция топирамата | |
UY26925A1 (es) | Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones | |
AR023138A1 (es) | Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso | |
PE20030545A1 (es) | Formulaciones de jarabe de ribavirina | |
ES2312921T3 (es) | Disolucion acuosa concentrada de ambroxol. | |
AR006345A1 (es) | Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion. | |
EP2845606B1 (en) | Medicament for the prevention, curing or abating cough and inflammations of the respiratory system | |
ES2318277T3 (es) | Composicion farmaceutica que compresnde acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico. | |
JP2002348236A (ja) | 医薬液剤 | |
UA79110C2 (en) | Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders | |
US12036317B2 (en) | Ready to use diclofenac stick packs | |
ES2310550T3 (es) | Preparacion liquida acuosa de pranoprofeno. | |
CO5580751A2 (es) | Nueva formulacion de jarabe de epinastina seco y acuoso | |
AR046665A1 (es) | Formulaciones orales de desoxipeganina y sus usos | |
JP2001316265A (ja) | オザグレルナトリウム含有注射液およびその安定化方法 | |
AR025393A1 (es) | Pildoras de desintegracion rapida basadas en quitosan | |
ES2194899T3 (es) | Composicion farmaceutica para administracion transdermica sistemica del principio activo morfina-6-glucuronido. | |
KR20000016365A (ko) | 니메술리드를 함유하는 경구 투여용 약제학적 제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150424 |